ВИРУСТЫҚ ACINETOBACTER BAUMANNII
Аннотация
Соңғы жылдары Acinetobacter baumannii - бүкіл әлемде таралған ең маңызды нозокомиалды қоздырғыштардың бірі. A. baumannii ауруханаларда ұзақ уақыт өмір сүру қабілетімен танымал, антибиотиктерге қарсы тұрақтылықтың дамуына бейім, сонымен қатар оның ауыр науқастардағы ауыр инфекциялар дамуындағы рөлі даусыз. Мақалада A. baumannii вируленттілігінің негізгі факторлары - ішкен, липополисахаридтер, сыртқы мембраналық везикулалар, липазалар, биофильмдер, эндотоксин, капсулалы полисахаридтер, секреция жүйесі сипатталған. Сипатталған вируленттілік факторлары және жинақталған қарсылық механизмдері ауыр нозокомиальды патогенді құрайды.
Әдебиет тізімі
1. Алексеева Е. И. Некоторые особенности эпидемического процесса внутрибольничных инфекций в детских ожоговых отделениях /Е. И. Алексеева, А. В. Слободенюк //Гигиена и эпидемиология. - 2007. - V. 1 (39). - P. 93 -95.
2. Acinetobacter baumannii is dependent on the type II secretion system and its substrate LipA for lipid utilization and in vivo fitness /T. L. Johnson, U. Waack, S. Smith et al. //J. Bacteriol. - 2015. - V. 198. - P. 711-719.
3. Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity /C. H. Choi, S. H. Hyun, J. Y. Lee et al. //Cell Microbiol. - 2008. - V. 10. - P. 309-319.
4. Acinetobacter baumannii utilizes a type VI secretion system for bacterial competition /M.D. Carruthers, P. A. Nicholson, E. N. Tracy et al. //PLoS ONE. - 2013. - V. 8. - e59388.
5. Acinetobacter: an emerging pathogen with a versatile secretome /M. Noha, L. Elhosseiny, A. Ahmed et al. //Elhosseiny and Attia Emerging Microbes & Infections. - 2018. - V. 7. -P. 33.
6. Alcoforado D. J. Molecular weaponry: diverse effectors delivered by the Type VI secretion system /D. J. Alcoforado, Y. C. Liu //Cell. Microbiol. - 2015. - V. 17. - P. 1742-1751.
7. Assessment of biofilm formation and resistance to imipenem and ciprofloxacin among clinical isolates of Acinetobacter baumannii in Tehran /A. Abdi-Ali, S. Hendiani, P. Mohammadi et al. //Microbiol. - 2014. - V. 7 (1). - P. 166168.
8. Assessment of insertion sequence mobilization as an adaptive response to oxidative stress in Acinetobacter baumannii using IS-Seq. / M. S. Wright, S. Mountain, K. Beeri et al. //J. Bacteriol. - 2017. - V. 199. - e00833-16.
9. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system /A. P. Tomaras, C. W. Dorsey, R. E. Edelmann et al. //Microbiol. - 2003. - V. 149. -P. 3473-3484.
10. Badave G. K. Biofilm Producing Multidrug Resistant Acinetobacter baumannii: An Emerging Challenge /G. K. Badave, D. Kulkarni // J. Clin. Diagn. Res. - 2015. - V. 9. - P. 8-9.
11. Bentancor L. V. Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii /L. V. Bentancor, A. Camacho-Peiro, C. Bozkurt-Guzel et al. //J. Bacteriol. - 2012. - V. 194. - P. 3950-3960.
12. Bergogne-Berezin E. Acinetobacter: Biology and Pathogenesis /E. Bergogne-Berezin, H. Friedman, M. Bendinelli //New York: Springer. - 2008. - P. 236.
13. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications /J. Rodriguez-Bano, S. Marti, S. Soto et al. //Clin. Microbiol. Infect. - 2008. - V. 14. - P. 276-278.
14. Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance /E. Babapour, A. Haddadi, R. Mirnejad et al. //Asian Pac. J. Trop. Biomed. - 2016. - V. 6 (6). - P. 528-533.
15. Brade H. Biological activities of the lipopolysaccharide and lipid A from Acinetobacter calcoaceticus /H. Brade, C. Galanos //J. Med. Microbiol. - 1983. - V. 16 (2). - P. 211-214.
16. Bravo Z. The long-term survival of Acinetobacter baumannii ATCC 19606T under nutrient-deprived conditions does not require the entry into the viable but non-culturable state // Arch. Microbiol. - 2016. - V. 198. - P. 399-407.
17. Brossard K. A. The Acinetobacter baumannii biofilmassociated protein plays a role in adherence to human epithelial cells /K. A. Brossard, A. A. Campagnari //Infect Immun. -2012. - V. 80 (1). - P. 228-233.
18. Cerqueira G. M. Insights into Acinetobacter baumannii pathogenicity /G. M. Cerqueira, A. Y. Peleg //IUBMB Life. - 2011. - V. 63 (12). -P. 1055-1060.
19. Characterization of bacterial biofilms formed on urinary catheters /R. Djeribi, W. Bouchloukh, T. Jouenne et al. //Am. J. Infect. Control. - 2012. - V. 40. - P. 854-859.
20. Clinical isolates of Acinetobacter baumannii from a Portuguese hospital: PFGE characterization, antibiotic susceptibility and biofilmforming ability /A. Duarte, S. Ferreira, S. Almeida et al. //Comp. Immunol. Microbiol. Infect. Dis. -2016. - V. 45. - P. 29-33.
21. Costs of healthcare and community-associated infections with antimicrobial-resistant versus antimicrobialsusceptible organisms /M. J. Neidell, B. Cohen, Y. Furuya et al. //Clin. Infect. Dis. - 2012. - V. 55. - P. 807-822.
22. De Gregorio E. Biofilm-associated proteins: news from Acinetobacter //BMC Genomics. - 2015. - V. 16. - P. 933.
23. Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity /L. C. Antunes, F. Imperi, A. Carattoli et al. //PLoS ONE. - 2011. - V. 6. - e22674.
24. Donlan R. M. Biofilms: survival mechanisms of clinically relevant microorganisms /R. M. Donlan, J. W. Costerton //Clin. Microbiol. Rev. -2002. - V. 15. - P. 67-193.
25. Effect of incubation temperature on antibiotic resistance and virulence factors of Acinetobacter baumannii ATCC 17978 /P. M. De Silva, P. Chong, D. M. Fernando et al. //Antimicrob. Agents. Chemother. - 2018. - V. 62 (1). -e01514-01517.
26. Effect of temperature and plumbing materials on biofilm formation by Legionella pneumophila serogroup 1 and 2-15 /A. Assaidi, M. Ellouali, H. Latrache et al. //J. Adhes. Sci. Technol. - 2018. - P. 1-14.
27. Eijkelkamp B. A. H-NS plays a role in expression of Acinetobacter baumannii virulence features //Infect. Immun. - 2013. - V. 81. - P. 2574-2583.
28. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii /E. Lautenbach, M. Synnestvedt, M. G. Weiner et al. // Infect. Control Hosp. Epidemiol. - 2009. - V. 30. - P. 1186-1278.
29. Falagas M. E. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue /M. E. Falagas, P. I. Rafailidis //Crit. Care. - 2007. - V. 11. - P. 134.
30. Gayoso C. M. Molecular mechanisms involved in the response to desiccation stress and persistence in Acinetobacter baumannii // Proteome Res. - 2014. - V. 13. - P. 460-476.
31. Giannouli M. Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78 //BMC Infect. Dis. - 2013. - V. 13. - P. 282.
32. Goh H. M. Molecular analysis of the Acinetobacter baumannii biofilm-associated protein //Appl. Environ. Microbiol. - 2013. - V. 79. -P. 6535-6543.
33. Harding C. M. Pathogenic Acinetobacter species have a functional type I secretion system and contactdependent inhibition systems //J. Biol. Chem. - 2017. - V. 292. - P. 9075-9087.
34. Harding C. M. Uncovering the mechanisms of Acinetobacter baumannii virulence /C. M. Harding, S. W. Hennon, M. F. Feldman //Nat. Rev. Microbiol. - 2018. - V. 16 (2). - P. 91-102.
35. Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis /N. R. Luke, S. L. Sauberan, T. A. Russo et al. //Infect Immun. - 2010. - V. 78. - P. 2017-2023.
36. Influence of temperature and surface kind on biofilm formation by Staphylococcus aureus from food-contact surfaces and sensitivity to sanitizers /Q. G. da Silva Meira, I. de Medeiros Barbosa, A. A. Athaydeet al. //Food Control. -2012. - V. 25 (2). - P. 469-475.
37. Influence of the alginate production on cell-to-cell communication in Pseudomonas aeruginosa PAO1 /J. Yang, M. Toyofuku, R. Sakai et al. //Environ. Microbiol. Rep. - 2017. - V. 9 (3). - P. 239-249.
38. Jun S. H. Acinetobacter baumannii outer membrane vesicles elicit a potent innate immune response via membrane proteins //PLoS ONE. - 2013. - V. 8. - e71751.
39. Juttukonda L. J. Acinetobacter baumannii coordinates urea metabolism with metal import to resist host-mediated metal limitation /L.J. Juttukonda W. J. Chazin, E. P. Skaar //mBio. -2016. - e01475-16.
40. Kinsella R. L. Defining the interaction of the protease CpaA with its type II secretion-chaperone CpaB and its contribution to virulence in Acinetobacter species //J. Biol. Chem. - 2017. - 808394.
41. Loehfelm T. W. Identification and characterization of an Acinetobacter baumannii biofilm-associated protein /T. W. Loehfelm, N. R. Luke, A. A. Campagnari //J. Bacteriol. - 2008. -V. 190 (3). - P. 1036-1044.
42. Longo F. Biofilm formation in Acinetobacter baumannii /F. Longo, C. Vuotto, G. Donelli //New Microbiologica. - 2014. - V. 37. -P. 119-127.
43. McConnell M. J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models /M. J. McConnell, L. Actis, J. Pachon //FEMS Microbiol. Rev. - 2013. - V. 37. P. 130-155.
44. Medically relevant acinetobacter species require a type II secretion system and specific membrane-associated chaperones for the export of multiple substrates and full virulence /C. M. Harding, R. L. Kinsella, L. D. Palmer et al. // PLoS Pathog. - 2016. - V. 12. - e1005391.
45. Molecular analysis and expression of bap gene in biofilm-forming multi drug-resistant Acinetobacter baumannii /O. Azizi, F. Shahcheraghi, H. Salimizand et al. //Rep. Biochem. Mol. Bio. - 2016. - V. 5 (1). - P. 62.
46. Multidrug resistance related to biofilm formation in Acinetobacter baumannii and Klebsiella pneumonia clinical strains from different pulsotype /P. A. de Campos, S. Royer, D. W. da Fonseca Batistao et al. //Curr. Microbiol. - 2016. - V. 72 (5). - P. 617-627.
47. Multi-resistant infections in repatriated patients after natural disasters: lessons learned from the 2004 tsunami for hospital infection control /I. Ugkay, H. Sax, S. Harbarth et al. //J. Hosp. Infect. - 2008. - V. 68. - P. 1-8.
48. Norton M. D. Antibiotic resistance acquired through a DNA damage-inducible response in Acinetobacter baumannii /M. D. Norton, A. J. Spilkia, V. G. Godoy //J. Bacteriol. - 2013. - V. 195. - P. 1335-1345.
49. Nowak P. Acinetobacter baumannii: biology and drug resistance - role of car-bapenemases /P. Nowak, P. Paluchowska //Folia histochemica et cytobiologica. - 2016. - V. 54 (2). - P. 61-74.
50. Peleg A. Y. Acinetobacter baumannii: emergence of a successful pathogen /A. Y. Peleg, H. Seifert, D. L. Paterson //Clin. Microbiol. Rev. -2008. - V. 21. - P. 538-620.
51. Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo /T. A. Russo, U. MacDonald, J. M. Beanan et al. //j. Infect. Dis. - 2009. - V. 199. - P. 513-521.
52. Perez A. The FhaB/FhaC two-partner secretion system is involved in adhesion of Acinetobacter baumannii AbH12O-A2 strain // Virulence. - 2016. - V. 8. - P. 959-974.
53. Potts M. Desiccation tolerance of prokaryotes //Microbiol. Rev. - 1994. - V. 58. - P. 755-805.
54. Prevalence and mapping of a plasmid encoding a type IV secretion system in Acinetobacter baumannii /C. C. Liu, H. Y. Kuo, C. Y. Tang et al. //Genomics. - 2014. - V. 104. - P. 215-223.
55. Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate /S. O. Kwon, Y. S. Gho, J. C. Lee et al. // FEMS Microbiol. Lett. - 2009. - V. 297. - P. 150156.
56. Quorum sensing integrates environmental cues, cell density and cell history to control bacterial competence /S. Moreno-Gamez, R. A. Sorg, A. Domenech et al. //Nat. Commun. -2017. - V. 8 (1). - P. 854.
57. Ramos-Gallardo G. Chronic wounds in burn injury: a case report on importance of biofilms //World. J. Plast. Surg. - 2016. - V. 5(2). -P. 175.
58. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant Enterococcus or the colonized patients' environment /M. K. Hayden, D. W. Blom, E. A. Lyle et al. //Infect. Control Hosp. Epidemiol. - 2008. - V. 29. - P. 149-154.
59. Sievert D. M. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010 // Infect. Control Hosp. Epidemiol. - 2013. - V. 34. - P. 1-14.
60. Stewart P. S. Antibiotic resistance of bacteria in biofilms /P. S Stewart, J. W. Costerton //The Lancet. - 2001. - V. 358 (9276). -P.135-138.
61. The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned PanDrug-Resistant Menace /I. Roca, P. Espinal, X. Vila-Farres et al. //Front Microbiol. - 2012. - V. 3. - P. 148.
62. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor /T. A. Russo, N. R. Luke, J. M. Beanan et al. //Infect. Immun. - 2010. - V. 78 (9). - P. 3993-4000.
63. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1 -6-N-acetylglucosamine, which is critical for biofilm formation /A. H. Choi, L. Slamti, F. Y. Avci et al. //J. Bacteriol. - 2009. - V. 191. - P. 59535963.
64. Touchon M. The genomic diversification of the whole Acinetobacter genus: origins, mechanisms, and consequences //Genome Biol. Evol. - 2014. - V. 6. - P. 2866-2882.
65. Villegas M. V. Acinetobacter outbreaks, 1977-2000 /M. V. Villegas, A. I. Hartstein //Infect. Control Hosp. Epidemiol. - 2003. - V.24. - P. 284-295.
66. Weber B. S Genomic and functional analysis of the type VI secretion system in Acinetobacter //PLoS ONE. - 2013. - V. 8. -e55142.
67. Weiner L. M. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014 // Infect. Control Hosp. Epidemiol. - 2016. - V. 37. - P. 1288-1301.
Рецензия
Дәйектеу үшін:
Лавриненко А.В. ВИРУСТЫҚ ACINETOBACTER BAUMANNII . Медицина және экология. 2019;(3):24-29.
For citation:
Lavrinenko A.V. VIRULENT ACINETOBACTER BAUMANNII. Medicine and ecology. 2019;(3):24-29. (In Russ.)
Қараулар:
235
Мақаланы эл. пошта арқылы жіберу 